Home
- Naturade Significantly Strengthens Balance Sheet; Receives $2.5 Million in Capital from Westgate Equity Partners, L.P.
- Natrol Appoints Vincent Andrich VP Sales for Prolab Division
- Vermont Pure Holdings, Ltd. Announces Record Fiscal Year 2001 Results
- Body Shop Reports 24.8 Mil Euro Sales Revenues
- Spectrum Organic Products Responds to FDA Letter Regarding Use of Non-GMO Seal on Canola Oil Label
- Supplement Group Targets Consumer Education
- Advanced Nutraceuticals, Inc. Announces 2001 Year End Results And Additional Financing
- ADM Awarded Nutraceuticals Patent Patent Creates Proprietary Position for ADM in Fast-Growing Nutraceutical Market
- Tantivy Sciences Obtains Exclusive License to Unique Nutraceutical Products
- Top GNC Executives Tour Pittsburgh Market to Present New Business Plan and Expansion Possibilities; Meeting will focus on new business strategies and growth
- Nutrition 21 Receives Patent For the Nutritional Treatment of Type 2 Diabetes; Patent Presents New Pharmaceutical Licensing Opportunities
- ConsumerLab.com Finds Most B-vitamin Supplements Contain What They Claim, But Often Exceed Safe Levels - Consumers Cautioned to Be Aware of Side Effects with High Dose Products
- Nutraceutix, Inc., Nutravite Announcement Commercial Availability of CDT™ Glucosamine for Canadian Marketplace
- Harvey Kamil Appointed President of NBTY, Inc. - Scott Rudolph to Continue as Chairman and CEO
- drugstore.com Expects to Reach Profitability Target in 2003
- Human Genome Project Leads to Innovative Healthcare
- NPIcenter’s Career Center targets nutraceutical Industry
- Adding Vitamin C To Certain Drugs May Help Treat Alzheimer's, Other Brain Disorders
- Adding Vitamin C To Certain Drugs May Help Treat Alzheimer's, Other Brain Disorders
- Editorial: An Exercise in Synergy
- NBTY, Inc. Appoints Harvey Kamil President, Scott Rudolph To Continue As Chairman And CEO
- Ross Products to Launch Infant Formula Supplemented With Two New Fatty Acids
- Ross Products to Launch Infant Formula Supplemented With Two New Fatty Acids
- Ross Products to Launch Infant Formula Supplemented With Two New Fatty Acids
- LignisulMSM vs Naproxen for Osteoarthritis Clinical Trial Gets Underway
- Natural Health Trends Corp. Launches Lexxus Taiwan
- FDA Presents Compliance Guide for Structure/Function Claims
- New TrimFit® Bars Redefine Energy Bar Category
- New TrimFit® Bars Redefine Energy Bar Category
- Probiata® Offers Safe, Natural and Effective Alternative
- Alive & Well with Michelle Harris
- Be Well and Get Rewarded! Find Personalized Wellness Solutions and Earn Free Vitamins at NatureMade.com
- Consumers Search for Healthy Cleaning Products That Work
- Nordic Naturals: Omega 3 Fatty Acids
- Cyanotech Names Bob Capelli as Director of Sales
- New Study: CLA May Serve Critical Role in Preventing Weight and Fat Gain During Year-End Holidays and with Normal Aging
A new study published online in the International Journal of Obesity suggests that Tonalin® CLA could have long-term health benefits by preventing weight and fat gain commonly experienced by adults during the November-December holiday season, and in the normal aging process.
- New Study: CLA May Serve Critical Role in Preventing Weight and Fat Gain During Year-End Holidays and with Normal Aging
A new study published online in the International Journal of Obesity suggests that Tonalin® CLA could have long-term health benefits by preventing weight and fat gain commonly experienced by adults during the November-December holiday season, and in the normal aging process.
- New Study: CLA May Serve Critical Role in Preventing Weight and Fat Gain During Year-End Holidays and with Normal Aging
A new study published online in the International Journal of Obesity suggests that Tonalin® CLA could have long-term health benefits by preventing weight and fat gain commonly experienced by adults during the November-December holiday season, and in the normal aging process.
- GliSODin study on oxidative stress in immune compromised humans included in the 2006 XVI International AIDS Conference
A study on Glisodin and immune compromised individuals at the AIDS 2006 - XVI International AIDS Conference, August 13-18 2006, held in Toronto. In the study, Glisodin was shown to restore the circulating antioxidant capacities, including Superoxide Dismustase (SOD), in the Glisodin group, compared to no change in the control and placebo group.
- GliSODin study on oxidative stress in immune compromised humans included in the 2006 XVI International AIDS Conference
A study on Glisodin and immune compromised individuals at the AIDS 2006 - XVI International AIDS Conference, August 13-18 2006, held in Toronto. In the study, Glisodin was shown to restore the circulating antioxidant capacities, including Superoxide Dismustase (SOD), in the Glisodin group, compared to no change in the control and placebo group.
- GliSODin study on oxidative stress in immune compromised humans included in the 2006 XVI International AIDS Conference
A study on Glisodin and immune compromised individuals at the AIDS 2006 - XVI International AIDS Conference, August 13-18 2006, held in Toronto. In the study, Glisodin was shown to restore the circulating antioxidant capacities, including Superoxide Dismustase (SOD), in the Glisodin group, compared to no change in the control and placebo group.
- GliSODin study on oxidative stress in immune compromised humans included in the 2006 XVI International AIDS Conference
A study on Glisodin and immune compromised individuals at the AIDS 2006 - XVI International AIDS Conference, August 13-18 2006, held in Toronto. In the study, Glisodin was shown to restore the circulating antioxidant capacities, including Superoxide Dismustase (SOD), in the Glisodin group, compared to no change in the control and placebo group.
- Vanderbilt-Ingram Cancer Center researchers find ginseng may improve breast cancer outcomes
Study by Vanderbilt-Ingram Cancer Center researchers, published online recently in the American Journal of Epidemiology, indicates that ginseng may improve survival and quality of life after a diagnosis of breast cancer
- Vanderbilt-Ingram Cancer Center researchers find ginseng may improve breast cancer outcomes
Study by Vanderbilt-Ingram Cancer Center researchers, published online recently in the American Journal of Epidemiology, indicates that ginseng may improve survival and quality of life after a diagnosis of breast cancer
- Vanderbilt-Ingram Cancer Center researchers find ginseng may improve breast cancer outcomes
Study by Vanderbilt-Ingram Cancer Center researchers, published online recently in the American Journal of Epidemiology, indicates that ginseng may improve survival and quality of life after a diagnosis of breast cancer
- Vanderbilt-Ingram Cancer Center researchers find ginseng may improve breast cancer outcomes
Study by Vanderbilt-Ingram Cancer Center researchers, published online recently in the American Journal of Epidemiology, indicates that ginseng may improve survival and quality of life after a diagnosis of breast cancer
- Broccoli Extract Studies Available on Web
Much of the research published on the positive beneficial effects of broccoli’s active component glucoraphanin and its hydrolyzed product sulforphane is available on the web site www.yoursgsmed.com.
- Broccoli Extract Studies Available on Web
Much of the research published on the positive beneficial effects of broccoli’s active component glucoraphanin and its hydrolyzed product sulforphane is available on the web site www.yoursgsmed.com.
- Broccoli Extract Studies Available on Web
Much of the research published on the positive beneficial effects of broccoli’s active component glucoraphanin and its hydrolyzed product sulforphane is available on the web site www.yoursgsmed.com.
- Broccoli Extract Studies Available on Web
Much of the research published on the positive beneficial effects of broccoli’s active component glucoraphanin and its hydrolyzed product sulforphane is available on the web site www.yoursgsmed.com.
- New Data Demonstrates Minimal Interactions Between Omacor(R) (Omega-3-Acid Ethyl Esters) and Simvastatin
Data in the July edition of the Journal of Clinical Pharmacology indicates that co-administration of Omacor (omega-3-acid ethyl esters) (4 g) with simvastatin (80 mg) has minimal interaction between the two drugs.
- New Data Demonstrates Minimal Interactions Between Omacor(R) (Omega-3-Acid Ethyl Esters) and Simvastatin
Data in the July edition of the Journal of Clinical Pharmacology indicates that co-administration of Omacor (omega-3-acid ethyl esters) (4 g) with simvastatin (80 mg) has minimal interaction between the two drugs.
- New Data Demonstrates Minimal Interactions Between Omacor(R) (Omega-3-Acid Ethyl Esters) and Simvastatin
Data in the July edition of the Journal of Clinical Pharmacology indicates that co-administration of Omacor (omega-3-acid ethyl esters) (4 g) with simvastatin (80 mg) has minimal interaction between the two drugs.
- New Data Demonstrates Minimal Interactions Between Omacor(R) (Omega-3-Acid Ethyl Esters) and Simvastatin
Data in the July edition of the Journal of Clinical Pharmacology indicates that co-administration of Omacor (omega-3-acid ethyl esters) (4 g) with simvastatin (80 mg) has minimal interaction between the two drugs.
- New Data Demonstrates Minimal Interactions Between Omacor(R) (Omega-3-Acid Ethyl Esters) and Simvastatin
Data in the July edition of the Journal of Clinical Pharmacology indicates that co-administration of Omacor (omega-3-acid ethyl esters) (4 g) with simvastatin (80 mg) has minimal interaction between the two drugs.
- Study Shows the Effectiveness of Oral Probiotic L. Rhamnosus GR-1™ and L. Reuteri RC-14™ In Treating Bacterial Vaginosis
Study published in Microbes and Infection demonstrated that the probiotic strains Lactobacillus rhamnosus GR-1™ and Lactobacillus reuteri RC-14™ were efficacious in treating bacterial vaginosis (BV) and increasing the population of beneficial lactobacillus organisms within the vagina.
- Study Shows the Effectiveness of Oral Probiotic L. Rhamnosus GR-1™ and L. Reuteri RC-14™ In Treating Bacterial Vaginosis
Study published in Microbes and Infection demonstrated that the probiotic strains Lactobacillus rhamnosus GR-1™ and Lactobacillus reuteri RC-14™ were efficacious in treating bacterial vaginosis (BV) and increasing the population of beneficial lactobacillus organisms within the vagina.
- Study Shows the Effectiveness of Oral Probiotic L. Rhamnosus GR-1™ and L. Reuteri RC-14™ In Treating Bacterial Vaginosis
Study published in Microbes and Infection demonstrated that the probiotic strains Lactobacillus rhamnosus GR-1™ and Lactobacillus reuteri RC-14™ were efficacious in treating bacterial vaginosis (BV) and increasing the population of beneficial lactobacillus organisms within the vagina.
- Study Shows the Effectiveness of Oral Probiotic L. Rhamnosus GR-1™ and L. Reuteri RC-14™ In Treating Bacterial Vaginosis
Study published in Microbes and Infection demonstrated that the probiotic strains Lactobacillus rhamnosus GR-1™ and Lactobacillus reuteri RC-14™ were efficacious in treating bacterial vaginosis (BV) and increasing the population of beneficial lactobacillus organisms within the vagina.
- Study: BioGaia´s Probiotic Oil Drops Halve Hospital Stay
A study involving 184 premature infants admitted to the neonatal intensive care unit immediately after delivery allocated the infants to one of three groups: 67 infants received BioGaia Reuteri Drops containing Lactobacillus reuteri Protectis (Reuteri), 55 infants received Lactobacilus rhamnosus GG (LGG), i.e. another probiotic, and 62 infants were treated only with the normal treatment (control group). In both the groups that received daily probiotics, the risk of infection by yeast (Candida) was reduced as was the incidence of bacterial infections. The Reuteri group had also further effects such as reduced occurrence of gastro-intestinal symptoms, earlier tolerance of food by mouth (intravenous nutrition could be stopped earlier), reduced weight loss during the first week of life, better growth during the first month of life and fewer days of hospitalisation.
- Study: BioGaia´s Probiotic Oil Drops Halve Hospital Stay
A study involving 184 premature infants admitted to the neonatal intensive care unit immediately after delivery allocated the infants to one of three groups: 67 infants received BioGaia Reuteri Drops containing Lactobacillus reuteri Protectis (Reuteri), 55 infants received Lactobacilus rhamnosus GG (LGG), i.e. another probiotic, and 62 infants were treated only with the normal treatment (control group). In both the groups that received daily probiotics, the risk of infection by yeast (Candida) was reduced as was the incidence of bacterial infections. The Reuteri group had also further effects such as reduced occurrence of gastro-intestinal symptoms, earlier tolerance of food by mouth (intravenous nutrition could be stopped earlier), reduced weight loss during the first week of life, better growth during the first month of life and fewer days of hospitalisation.
- Low vitamin E intake during pregnancy can lead to childhood asthma
Research appearing in the September issue of of the American Journal of Respiratory and Critical Care Medicine indicates that children whose mothers had a low intake of vitamin E during pregnancy are more likely to develop wheezing and asthma by age five.
- Low vitamin E intake during pregnancy can lead to childhood asthma
Research appearing in the September issue of of the American Journal of Respiratory and Critical Care Medicine indicates that children whose mothers had a low intake of vitamin E during pregnancy are more likely to develop wheezing and asthma by age five.
- Low vitamin E intake during pregnancy can lead to childhood asthma
Research appearing in the September issue of of the American Journal of Respiratory and Critical Care Medicine indicates that children whose mothers had a low intake of vitamin E during pregnancy are more likely to develop wheezing and asthma by age five.
- Low vitamin E intake during pregnancy can lead to childhood asthma
Research appearing in the September issue of of the American Journal of Respiratory and Critical Care Medicine indicates that children whose mothers had a low intake of vitamin E during pregnancy are more likely to develop wheezing and asthma by age five.
- Low vitamin E intake during pregnancy can lead to childhood asthma
Research appearing in the September issue of of the American Journal of Respiratory and Critical Care Medicine indicates that children whose mothers had a low intake of vitamin E during pregnancy are more likely to develop wheezing and asthma by age five.
- Study Shows That Pine Tree Bark Reduces Diabetic Leg Ulcers
Study published in the July journal of Clinical and Applied Thrombosis/Homeostasis shows that Pycnogenol heals leg ulcers in patients who suffer from diabetic leg ulcerations.
- Study Shows That Pine Tree Bark Reduces Diabetic Leg Ulcers
Study published in the July journal of Clinical and Applied Thrombosis/Homeostasis shows that Pycnogenol heals leg ulcers in patients who suffer from diabetic leg ulcerations.
- Study Shows That Pine Tree Bark Reduces Diabetic Leg Ulcers
Study published in the July journal of Clinical and Applied Thrombosis/Homeostasis shows that Pycnogenol heals leg ulcers in patients who suffer from diabetic leg ulcerations.
- Study Shows That Pine Tree Bark Reduces Diabetic Leg Ulcers
Study published in the July journal of Clinical and Applied Thrombosis/Homeostasis shows that Pycnogenol heals leg ulcers in patients who suffer from diabetic leg ulcerations.
- NSF International Awards First GMP for Sport(TM) Registration to Century Foods International
NSF International announced that Century Foods International is the first manufacturing facility to receive Good Manufacturing Practices (GMP) for Sport™ registration, a new program that builds on NSF’s GMP Registration Program.
- NSF International Awards First GMP for Sport(TM) Registration to Century Foods International
NSF International announced that Century Foods International is the first manufacturing facility to receive Good Manufacturing Practices (GMP) for Sport™ registration, a new program that builds on NSF’s GMP Registration Program.
- NSF International Awards First GMP for Sport(TM) Registration to Century Foods International
NSF International announced that Century Foods International is the first manufacturing facility to receive Good Manufacturing Practices (GMP) for Sport™ registration, a new program that builds on NSF’s GMP Registration Program.
- NSF International Awards First GMP for Sport(TM) Registration to Century Foods International
NSF International announced that Century Foods International is the first manufacturing facility to receive Good Manufacturing Practices (GMP) for Sport™ registration, a new program that builds on NSF’s GMP Registration Program.
- NSF International Awards First GMP for Sport(TM) Registration to Century Foods International
NSF International announced that Century Foods International is the first manufacturing facility to receive Good Manufacturing Practices (GMP) for Sport™ registration, a new program that builds on NSF’s GMP Registration Program.
- NSF International Awards First GMP for Sport(TM) Registration to Century Foods International
NSF International announced that Century Foods International is the first manufacturing facility to receive Good Manufacturing Practices (GMP) for Sport™ registration, a new program that builds on NSF’s GMP Registration Program.
- AHP Introduces New Quality Botanical Macroscopy Profile™
AHP Introduces New Quality Botanical Macroscopy Profile™ - Authoritative Guide Features 11 Species at Special Introductory Price
- AHP Introduces New Quality Botanical Macroscopy Profile™
AHP Introduces New Quality Botanical Macroscopy Profile™ - Authoritative Guide Features 11 Species at Special Introductory Price
- New Study Demonstrates Dietary Supplement Lutein Increases Skin Hydration, Elasticity and Lipid Levels
Highlights from a new clinical study presented today at the "Beyond Beauty Paris" conference in France provide compelling evidence that lutein, a dietary nutrient available as a supplement and long-known for its effectiveness in promoting eye health, also provides specific skin health benefits including increasing the hydration, elasticity and superficial lipids of the skin, while decreasing the oxidation of those skin lipids.
- New Study Demonstrates Dietary Supplement Lutein Increases Skin Hydration, Elasticity and Lipid Levels
Highlights from a new clinical study presented today at the "Beyond Beauty Paris" conference in France provide compelling evidence that lutein, a dietary nutrient available as a supplement and long-known for its effectiveness in promoting eye health, also provides specific skin health benefits including increasing the hydration, elasticity and superficial lipids of the skin, while decreasing the oxidation of those skin lipids.
- New Study Demonstrates Dietary Supplement Lutein Increases Skin Hydration, Elasticity and Lipid Levels
Highlights from a new clinical study presented today at the "Beyond Beauty Paris" conference in France provide compelling evidence that lutein, a dietary nutrient available as a supplement and long-known for its effectiveness in promoting eye health, also provides specific skin health benefits including increasing the hydration, elasticity and superficial lipids of the skin, while decreasing the oxidation of those skin lipids.
- New Study Demonstrates Dietary Supplement Lutein Increases Skin Hydration, Elasticity and Lipid Levels
Highlights from a new clinical study presented today at the "Beyond Beauty Paris" conference in France provide compelling evidence that lutein, a dietary nutrient available as a supplement and long-known for its effectiveness in promoting eye health, also provides specific skin health benefits including increasing the hydration, elasticity and superficial lipids of the skin, while decreasing the oxidation of those skin lipids.
- Recent Studies Reveal Cranberries Disable Certain Harmful E. coli Bacteria
According to a new laboratory study conducted by researchers from Worcester Polytechnic Institute, cranberry PACs disable certain E. coli bacteria and may prevent the attachment of microorganisms that cause infection by changing the shape of the bacteria from rods to spheres, altering their cell membrane, and making it difficult for bacteria to make contact with cells, or from latching onto them should they get close enough.
- Recent Studies Reveal Cranberries Disable Certain Harmful E. coli Bacteria
According to a new laboratory study conducted by researchers from Worcester Polytechnic Institute, cranberry PACs disable certain E. coli bacteria and may prevent the attachment of microorganisms that cause infection by changing the shape of the bacteria from rods to spheres, altering their cell membrane, and making it difficult for bacteria to make contact with cells, or from latching onto them should they get close enough.
- Acatris Flax Lignan Product Proven Bioavailable
A recent human clinical pilot study conducted by the Kanda Ishin Clinic in Tokyo, Japan has shown that flax lignans from Acatris’ LinumLife product are bioavailable.
- Acatris Flax Lignan Product Proven Bioavailable
A recent human clinical pilot study conducted by the Kanda Ishin Clinic in Tokyo, Japan has shown that flax lignans from Acatris’ LinumLife product are bioavailable.
- Prenatal Vitamins May Reduce Risk of Brain Tumors in Children
Study conducted at The Children's Hospital of Philadelphia, appearing in the September issue of Cancer Epidemiology Biomarkers & Prevention, suggests that women who take multivitamins early in pregnancy may reduce the risk that their child will develop some types of brain tumors.
- Prenatal Vitamins May Reduce Risk of Brain Tumors in Children
Study conducted at The Children's Hospital of Philadelphia, appearing in the September issue of Cancer Epidemiology Biomarkers & Prevention, suggests that women who take multivitamins early in pregnancy may reduce the risk that their child will develop some types of brain tumors.
- Prenatal Vitamins May Reduce Risk of Brain Tumors in Children
Study conducted at The Children's Hospital of Philadelphia, appearing in the September issue of Cancer Epidemiology Biomarkers & Prevention, suggests that women who take multivitamins early in pregnancy may reduce the risk that their child will develop some types of brain tumors.
- Prenatal Vitamins May Reduce Risk of Brain Tumors in Children
Study conducted at The Children's Hospital of Philadelphia, appearing in the September issue of Cancer Epidemiology Biomarkers & Prevention, suggests that women who take multivitamins early in pregnancy may reduce the risk that their child will develop some types of brain tumors.
- Prenatal Vitamins May Reduce Risk of Brain Tumors in Children
Study conducted at The Children's Hospital of Philadelphia, appearing in the September issue of Cancer Epidemiology Biomarkers & Prevention, suggests that women who take multivitamins early in pregnancy may reduce the risk that their child will develop some types of brain tumors.
- Significant Advances In Dietary Supplement Research Released In Annual Bibliography (2005)
The Office of Dietary Supplements (ODS) at the National Institutes of Health (NIH) has announced the release of the 2005 issue of the Annual Bibliography of Significant Advances in Dietary Supplement Research, including abstracts of 25 noteworthy dietary supplement research papers published in 2005, as judged by an international team of reviewers.
- Significant Advances In Dietary Supplement Research Released In Annual Bibliography (2005)
The Office of Dietary Supplements (ODS) at the National Institutes of Health (NIH) has announced the release of the 2005 issue of the Annual Bibliography of Significant Advances in Dietary Supplement Research, including abstracts of 25 noteworthy dietary supplement research papers published in 2005, as judged by an international team of reviewers.
- Study: Astaxanthin Prevents the Onset Of Asthenopia
Company announces the publication of the ninth clinical study on AstaReal® astaxanthin for the reduction of asthenopia (eye fatigue). The effects of astaxanthin on eyestrain induced by accommodative dysfunction were investigated at the University of Occupational and Environmental Health, Department of Ophthalmology, Japan. Results showed a significant improvement in the astaxanthin supplemented group over the placebo group.
- Study: Astaxanthin Prevents the Onset Of Asthenopia
Company announces the publication of the ninth clinical study on AstaReal® astaxanthin for the reduction of asthenopia (eye fatigue). The effects of astaxanthin on eyestrain induced by accommodative dysfunction were investigated at the University of Occupational and Environmental Health, Department of Ophthalmology, Japan. Results showed a significant improvement in the astaxanthin supplemented group over the placebo group.
- Study: Astaxanthin Prevents the Onset Of Asthenopia
Company announces the publication of the ninth clinical study on AstaReal® astaxanthin for the reduction of asthenopia (eye fatigue). The effects of astaxanthin on eyestrain induced by accommodative dysfunction were investigated at the University of Occupational and Environmental Health, Department of Ophthalmology, Japan. Results showed a significant improvement in the astaxanthin supplemented group over the placebo group.
- Study: Astaxanthin Prevents the Onset Of Asthenopia
Company announces the publication of the ninth clinical study on AstaReal® astaxanthin for the reduction of asthenopia (eye fatigue). The effects of astaxanthin on eyestrain induced by accommodative dysfunction were investigated at the University of Occupational and Environmental Health, Department of Ophthalmology, Japan. Results showed a significant improvement in the astaxanthin supplemented group over the placebo group.
- Study: Astaxanthin Prevents the Onset Of Asthenopia
Company announces the publication of the ninth clinical study on AstaReal® astaxanthin for the reduction of asthenopia (eye fatigue). The effects of astaxanthin on eyestrain induced by accommodative dysfunction were investigated at the University of Occupational and Environmental Health, Department of Ophthalmology, Japan. Results showed a significant improvement in the astaxanthin supplemented group over the placebo group.
- Clinical Study Proves vitaminwater Works
Clinical study to be presented at the American College of Nutrition conference indicates that vitaminwater® power-c more effectively delivers useable vitamins to the body than traditional foods at a fifth of the calories.
- Clinical Study Proves vitaminwater Works
Clinical study to be presented at the American College of Nutrition conference indicates that vitaminwater® power-c more effectively delivers useable vitamins to the body than traditional foods at a fifth of the calories.
- Clinical Study Proves vitaminwater Works
Clinical study to be presented at the American College of Nutrition conference indicates that vitaminwater® power-c more effectively delivers useable vitamins to the body than traditional foods at a fifth of the calories.
- Clinical Study Proves vitaminwater Works
Clinical study to be presented at the American College of Nutrition conference indicates that vitaminwater® power-c more effectively delivers useable vitamins to the body than traditional foods at a fifth of the calories.
- Boron, Omega-3 Fatty Acids Promote Bone Strength
Researchers from the USDA’s (United States Department of Agriculture) Grand Forks Human Nutrition Research Center fed rat pups either a low or boron-supplemented diet with palm (low omega-3) or canola (high omega-3) oil and then tested femur strength and tibial concentrations of certain minerals. Bone strength and flexibility were lowest in the boron-deprived rats fed canola oil, yet were greatest in boron-supplemented rats fed canola oil.
- Boron, Omega-3 Fatty Acids Promote Bone Strength
Researchers from the USDA’s (United States Department of Agriculture) Grand Forks Human Nutrition Research Center fed rat pups either a low or boron-supplemented diet with palm (low omega-3) or canola (high omega-3) oil and then tested femur strength and tibial concentrations of certain minerals. Bone strength and flexibility were lowest in the boron-deprived rats fed canola oil, yet were greatest in boron-supplemented rats fed canola oil.
- Boron, Omega-3 Fatty Acids Promote Bone Strength
Researchers from the USDA’s (United States Department of Agriculture) Grand Forks Human Nutrition Research Center fed rat pups either a low or boron-supplemented diet with palm (low omega-3) or canola (high omega-3) oil and then tested femur strength and tibial concentrations of certain minerals. Bone strength and flexibility were lowest in the boron-deprived rats fed canola oil, yet were greatest in boron-supplemented rats fed canola oil.
- Frost & Sullivan Honours GAT Food Essentials GmbH With European Functional Food & Beverage Microencapsulation Technology Innovation Award
The 2009 Frost & Sullivan European Functional Food & Beverage Microencapsulation Technology Innovation Award has been presented to GAT Food Essentials GmbH in recognition of its proprietary wowCAPS(R) technology.
- Frost & Sullivan Honours GAT Food Essentials GmbH With European Functional Food & Beverage Microencapsulation Technology Innovation Award
The 2009 Frost & Sullivan European Functional Food & Beverage Microencapsulation Technology Innovation Award has been presented to GAT Food Essentials GmbH in recognition of its proprietary wowCAPS(R) technology.
- Frost & Sullivan Honours GAT Food Essentials GmbH With European Functional Food & Beverage Microencapsulation Technology Innovation Award
The 2009 Frost & Sullivan European Functional Food & Beverage Microencapsulation Technology Innovation Award has been presented to GAT Food Essentials GmbH in recognition of its proprietary wowCAPS(R) technology.
- BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates
Bio-Extraction Inc., has announced that it has completed the self-affirmation process to qualify its specialty canola protein products, Isolexx(TM) and Vitalexx(TM), as self-affirmed GRAS for their intended use in various foods and beverages, thus providing a basis for the sale of these products in the United States when commercial production commences in Q1 2010.
- BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates
Bio-Extraction Inc., has announced that it has completed the self-affirmation process to qualify its specialty canola protein products, Isolexx(TM) and Vitalexx(TM), as self-affirmed GRAS for their intended use in various foods and beverages, thus providing a basis for the sale of these products in the United States when commercial production commences in Q1 2010.
- BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates
Bio-Extraction Inc., has announced that it has completed the self-affirmation process to qualify its specialty canola protein products, Isolexx(TM) and Vitalexx(TM), as self-affirmed GRAS for their intended use in various foods and beverages, thus providing a basis for the sale of these products in the United States when commercial production commences in Q1 2010.
- BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates
Bio-Extraction Inc., has announced that it has completed the self-affirmation process to qualify its specialty canola protein products, Isolexx(TM) and Vitalexx(TM), as self-affirmed GRAS for their intended use in various foods and beverages, thus providing a basis for the sale of these products in the United States when commercial production commences in Q1 2010.
- BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates
Bio-Extraction Inc., has announced that it has completed the self-affirmation process to qualify its specialty canola protein products, Isolexx(TM) and Vitalexx(TM), as self-affirmed GRAS for their intended use in various foods and beverages, thus providing a basis for the sale of these products in the United States when commercial production commences in Q1 2010.
- BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates
Bio-Extraction Inc., has announced that it has completed the self-affirmation process to qualify its specialty canola protein products, Isolexx(TM) and Vitalexx(TM), as self-affirmed GRAS for their intended use in various foods and beverages, thus providing a basis for the sale of these products in the United States when commercial production commences in Q1 2010.
- BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates
Bio-Extraction Inc., has announced that it has completed the self-affirmation process to qualify its specialty canola protein products, Isolexx(TM) and Vitalexx(TM), as self-affirmed GRAS for their intended use in various foods and beverages, thus providing a basis for the sale of these products in the United States when commercial production commences in Q1 2010.
- BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates
Bio-Extraction Inc., has announced that it has completed the self-affirmation process to qualify its specialty canola protein products, Isolexx(TM) and Vitalexx(TM), as self-affirmed GRAS for their intended use in various foods and beverages, thus providing a basis for the sale of these products in the United States when commercial production commences in Q1 2010.
- BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates
Bio-Extraction Inc., has announced that it has completed the self-affirmation process to qualify its specialty canola protein products, Isolexx(TM) and Vitalexx(TM), as self-affirmed GRAS for their intended use in various foods and beverages, thus providing a basis for the sale of these products in the United States when commercial production commences in Q1 2010.
- Synergy Flavors Invests in Sensory Flavor Profiling Research
Synergy Flavors has commissioned a new research program at North Carolina State University to study the sensory profiles of a range of protein ingredients.
- Synergy Flavors Invests in Sensory Flavor Profiling Research
Synergy Flavors has commissioned a new research program at North Carolina State University to study the sensory profiles of a range of protein ingredients.
- Synergy Flavors Invests in Sensory Flavor Profiling Research
Synergy Flavors has commissioned a new research program at North Carolina State University to study the sensory profiles of a range of protein ingredients.
- Synergy Flavors Invests in Sensory Flavor Profiling Research
Synergy Flavors has commissioned a new research program at North Carolina State University to study the sensory profiles of a range of protein ingredients.
- Synergy Flavors Invests in Sensory Flavor Profiling Research
Synergy Flavors has commissioned a new research program at North Carolina State University to study the sensory profiles of a range of protein ingredients.
- Beat Crazy Cocoa Prices with Synergy's Chocolate Flavors
Synergy Flavors Inc., has announced their chocolate flavors offer a versatile solution for cocoa reduction and can be used as cocoa extenders.
- Beat Crazy Cocoa Prices with Synergy's Chocolate Flavors
Synergy Flavors Inc., has announced their chocolate flavors offer a versatile solution for cocoa reduction and can be used as cocoa extenders.
- Beat Crazy Cocoa Prices with Synergy's Chocolate Flavors
Synergy Flavors Inc., has announced their chocolate flavors offer a versatile solution for cocoa reduction and can be used as cocoa extenders.
- Beat Crazy Cocoa Prices with Synergy's Chocolate Flavors
Synergy Flavors Inc., has announced their chocolate flavors offer a versatile solution for cocoa reduction and can be used as cocoa extenders.
- Beat Crazy Cocoa Prices with Synergy's Chocolate Flavors
Synergy Flavors Inc., has announced their chocolate flavors offer a versatile solution for cocoa reduction and can be used as cocoa extenders.
- Beat Crazy Cocoa Prices with Synergy's Chocolate Flavors
Synergy Flavors Inc., has announced their chocolate flavors offer a versatile solution for cocoa reduction and can be used as cocoa extenders.
- Beat Crazy Cocoa Prices with Synergy's Chocolate Flavors
Synergy Flavors Inc., has announced their chocolate flavors offer a versatile solution for cocoa reduction and can be used as cocoa extenders.
- NPI Daily - Top of The News for Nov. 20, 2009 - FDA Issues 22 Warning Letters to Website Operators
Frost & Sullivan Honours GAT Food Essentials GmbH With European Functional Food & Beverage Microencapsulation Technology Innovation Award; Synergy Flavors Invests in Sensory Flavor Profiling Research; FDA Issues 22 Warning Letters to Website Operators; Nordic Naturals Ultimate Omega™ First Fish Oil to Participate in NFL/NFLPA Sports Nutrition Label Certification Program; BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates; New Organic Berry Whole Food Energy Bar from Amazing Grass Delivers Whole Food Nutrition; Beat Crazy Cocoa Prices with Synergy's Chocolate Flavors
- NPI Daily - Top of The News for Nov. 20, 2009 - FDA Issues 22 Warning Letters to Website Operators
Frost & Sullivan Honours GAT Food Essentials GmbH With European Functional Food & Beverage Microencapsulation Technology Innovation Award; Synergy Flavors Invests in Sensory Flavor Profiling Research; FDA Issues 22 Warning Letters to Website Operators; Nordic Naturals Ultimate Omega™ First Fish Oil to Participate in NFL/NFLPA Sports Nutrition Label Certification Program; BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates; New Organic Berry Whole Food Energy Bar from Amazing Grass Delivers Whole Food Nutrition; Beat Crazy Cocoa Prices with Synergy's Chocolate Flavors
- Heart Health Alert: Niacin May Reverse Hardening of the Arteries
- Heart Health Alert: Niacin May Reverse Hardening of the Arteries
- Heart Health Alert: Niacin May Reverse Hardening of the Arteries
- Heart Health Alert: Niacin May Reverse Hardening of the Arteries
- Spotlight on Savory Side Dishes
- Spotlight on Savory Side Dishes
- Spotlight on Savory Side Dishes
- Another Reason to Choose Healthy Lifestyle Habits
- Another Reason to Choose Healthy Lifestyle Habits
|
Los Angeles, CA, September 5, 2006 –The results of a clinical trial investigating the effects of Jarrow Formulas® Q-absorb™, an enhanced-absorption CoQ10 formula, on chronic heart failure patients was recently published in the European Heart Journal.
Italian scientists from the Lancisi Heart Institute and the University of Ancona (Institute of Biochemistry) measured the effects of 300 mg per day (100 mg T.I.D.) Q-absorb™ on the cardiovascular functional capacity of 23 heart patients. Measurements included endothelial-dependent vasodilation as measured by ultrasound BART (brachial artery reactivity test), plasma ubiquinone, and other important cardiovascular biochemical parameters. In this randomized, placebo-controlled, double-blind, crossover clinical trial, the study results proved the efficacy of Q-absorb™, as demonstrated by:
• improving functional capacity (peak volume of oxygen consumed VO2)
• improvement in endothelial-dependent vasodilation
• tripling of plasma coenzyme Q 10 levels (p<0.0001)
One experimental arm consisted of Chronic Heart Failure patients administered Q-absorb™ plus a prescribed exercise regimen, which resulted in the greatest gains of plasma Q, with endothelial function being almost normalized. Endothelial function, as measured by the Brachial Artery Reactivity Test, is a non-invasive, preliminary test for cardiovascular disease. The scientists theorized that Q-absorb™ enhanced the endothelial-dependent vasodilation by its effects of reducing ROS (reactive oxygen species), thus resulting in the elevation of nitric oxide.
“This study adds significantly to a growing body of evidence that CoQ10 supplementation may be an efficacious complementary method for improving cardiac function in heart failure patients,” says Kevin Connolly, Ph.D, Director of Scientific Affairs and Product Development at Jarrow Formulas. “It [the study] also validates that our Q-Absorb as a successful natural delivery system for CoQ10, an antioxidant that typically exhibits poor bioavailability. Prior to this study, we had invested several years into the development and study of Q-absorb™, and we are excited to see it perform so successfully in patients.”
Jarrow Formulas is a nutritional supplement formulator and marketer founded in 1977 and incorporated in 1988. The company markets its products throughout the United States and internationally in more than 20 countries in Europe, Asia, Israel and Latin America. The company offers a complete line of nutritional products that includes vitamins, minerals, probiotics, standardized herbal concentrates, amino acids, enzymes and enteral nutrition formulations. Jarrow Formulas, Inc. is active in regulatory affairs, helping to maintain American’s rights to free access to dietary supplements. Its products are manufactured by Jarrow Industries Incorporated, a pharmaceutical quality facility located in Santa Fe Springs, CA. For more information, contact Mark Becker, Director, Advertising/Communications toll free at (800) 726-0886 or access the Jarrow Formulas Web site at www.Jarrow.com.
### |